# Individualized Treatment of Patients With Advanced NSCLC: Potential Application for Circulating Tumor Cells (CTC) Molecular and Phenotypical Profiling

> **NCT02407327** · — · COMPLETED · sponsor: **Istituto Oncologico Veneto IRCCS** · enrollment: 215 (actual)

## Conditions studied

- Advanced Non Small Cell Lung Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02407327
- **Lead sponsor:** Istituto Oncologico Veneto IRCCS
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12-01
- **Primary completion:** 2016-12-01
- **Final completion:** 2016-12-01
- **Target enrollment:** 215 (ACTUAL)
- **Last updated:** 2023-11-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02407327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02407327, "Individualized Treatment of Patients With Advanced NSCLC: Potential Application for Circulating Tumor Cells (CTC) Molecular and Phenotypical Profiling". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT02407327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*